© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - OPKO Health Acquires EirGen Pharma
Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography
Image

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
The Race to Net Zero: How Businesses Can Cut Energy Costs and Carbon Emissions Simultaneously
Corporate Social Responsibility
15/04/2025The Race to Net Zero: How Businesses Can Cut Energy Costs and Carbon Emissions Simultaneously

Andrew King is the founder of SGT, a Buckinghamshire-based firm helping businesses across the UK find commercial energy tariffs that meet their needs while keeping costs low. Andrew explores how businesses can cut energy costs while also cutting down their car

Read Full PostRead - Eye Icon
How Can Insurance Protect Businesses During Daily Operations?
News
12/01/2023How Can Insurance Protect Businesses During Daily Operations?

What type of business do you run? Is it small or large? Are you self-employed? Whatever your business looks like, it’s worth thinking about the type of cover you’ll need in order to protect you, your employees and your company from any unexpected costs tha

Read Full PostRead - Eye Icon
Best Lease Accounting Software of 2026: From Compliance to Cashflow
Finance
11/05/2026Best Lease Accounting Software of 2026: From Compliance to Cashflow

The grace period for private companies adopting ASC 842 is expiring, while IFRS 16 post-implementation reviews are tightening auditor expectations worldwide. Boards now want lease data that is as fast and audit-ready as revenue numbers—which makes spread

Read Full PostRead - Eye Icon
Three Tips for Keeping Your Business’ Data Secure
News
21/07/2023Three Tips for Keeping Your Business’ Data Secure

Businesses worldwide are always looking for ways to improve the efficiency of their business and add more security. After all, there are many reasons for business owners to be concerned. There may be a lot of important data and information at risk.

Read Full PostRead - Eye Icon
6 Small Business Costs that are Often Overlooked
Finance
03/11/20206 Small Business Costs that are Often Overlooked

Most people who start a small business may be aware of the general costs of incorporating their business, buying initial inventory, and securing a location. Then they start looking into the everyday operational and organisational costs. But there always seem t

Read Full PostRead - Eye Icon
What You Need to Know About Microsoft 365 Copilot, the Ultimate AI Assistant
Innovation
25/01/2024What You Need to Know About Microsoft 365 Copilot, the Ultimate AI Assistant

Microsoft 365 Copilot is the new AI powered solution from Microsoft, and it looks set to revolutionise the way we work. Microsoft have this week announced they are removing the 300-seat purchase minimum for commercial plans and making Microsoft 365 Copilot ava

Read Full PostRead - Eye Icon
Understanding the Benefits and Importance of Installment Loans
Finance
11/01/2022Understanding the Benefits and Importance of Installment Loans

Installment loans could be a real game-changer, especially if you need flexible repayments. In these difficult economic moments, you find that you will need some cash at some point. And that's why you need to know about installment loans.

Read Full PostRead - Eye Icon
Focus Starts 2016 Strong by Helping its Partner Firms Close Three Mergers
M&A
25/01/2016Focus Starts 2016 Strong by Helping its Partner Firms Close Three Mergers

Focus Financial Partners (‘Focus’) today announced the closing of merger deals for three of its partner firms – Benefit Funding Services Group, Bridgewater Wealth & Financial Management and Buckingham Asset Management. The Focus partner firms are poised

Read Full PostRead - Eye Icon
Closure of Polaris Private Equity IV at €300m
Finance
12/03/2015Closure of Polaris Private Equity IV at €300m

Polaris Private Equity (“Polaris”), the leading Danish/Swedish lower mid-market private equity investor, is pleased to announce that it has successfully completed a first closing of its fourth private equity fund – Polaris Private Equity IV – at DKK 2.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow